Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease-Reference-Cited by-同舟云学术

Expression and secretion of CXCL12 are enhanced in autosomal dominant polycystic kidney disease

Published:2019-07-31 Issue:7 Volume:52 Page:463-468
ISSN:1976-670X
Container-title:BMB Reports
language:en
Short-container-title:BMB Rep.

Author:

Kim Hyunho¹,Sung Jinmo¹,Kim Hyunsuk²,Ryu Hyunjin³,Park Hayne Cho⁴,Oh Yun Kyu⁵,Lee Hyun-Seob⁶,Oh Kook-Hwan³,Ahn Curie³

Affiliation:

1. Center for Medical Innovation, Biomedical Research Institute, Seoul National University Hospital, Seoul 03082, Korea

2. Internal Medicine, Hallym University Medical Center, Chuncheon Sacred Heart Hospital, Chuncheon 24253, Korea

3. Department of Internal Medicine, Seoul National University College of Medicine, Seoul 03080, Korea

4. Department of Internal Medicine, Hallym University Medical Center, Kangnam Sacred Heart Hospital, Seoul 07441, Korea

5. Department of Internal Medicine, Seoul National University Boramae Medical Center, Seoul 07061, Korea

6. Genomics Core Facility, Department of Transdisciplinary Research and Collaboration, Biomedical Research Institute, Seoul National University Hospital, Seoul 03082, Korea

Funder

National Research Foundation of Korea

Ministry of Science and ICT

Publisher

Korean Society for Biochemistry and Molecular Biology - BMB Reports

Subject

Molecular Biology,Biochemistry,General Medicine

Link

http://pdf.medrang.co.kr/BMB/2019/052/BMB052-07-08.pdf

Reference22 articles.

1. Autosomal dominant polycystic kidney disease: modification of disease progression

2. Polycystic Kidney Disease

3. Polycystic Kidney Disease

4. Autosomal dominant polycystic kidney disease: Molecular genetics and pathophysiology

5. An unusual pattern of mutation in the duplicated portion of PKD1 is revealed by use of a novel strategy for mutation detection

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HL156A, an AMP-Activated Protein Kinase Activator, Inhibits Cyst Growth in Autosomal Dominant Polycystic Kidney Disease;Biomolecules;2024-07-07

2. Transcriptomic profiling of Polycystic Kidney Disease identifies paracrine factors in the early cyst microenvironment;Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease;2024-02

3. CXCL12-CXCR4/CXCR7 Axis in Cancer: from Mechanisms to Clinical Applications;International Journal of Biological Sciences;2023

4. Identification of osteopontin as a urinary biomarker for autosomal dominant polycystic kidney disease progression;Kidney Research and Clinical Practice;2022-11-30

5. Diabetic proximal tubulopathy: Can we mimic the disease for in vitro screening of SGLT inhibitors?;European Journal of Pharmacology;2021-10